Clinical Trial Update: Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

View source ↗

Summary

GlaxoSmithKline completed a validation study using the MarketScan database to examine whether adherence to benign prostatic hyperplasia treatment is associated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Status: COMPLETED